These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33036201)

  • 1. A Partially Hydrolyzed Whey Infant Formula Supports Appropriate Growth: A Randomized Controlled Non-Inferiority Trial.
    Karaglani E; Thijs-Verhoeven I; Gros M; Chairistanidou C; Zervas G; Filoilia C; Kampani TM; Miligkos V; Matiatou M; Valaveri S; Sakellariou A; Babilis G; Bos R; Manios Y
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33036201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial.
    Picaud JC; Pajek B; Arciszewska M; Tarczón I; Escribano J; Porcel R; Adelt T; Hassink E; Rijnierse A; Abrahamse-Berkeveld M; Korczowski B; On Behalf Of The Tenuto Study Group
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32668666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth of healthy term infants fed partially hydrolyzed whey-based infant formula: a randomized, blinded, controlled trial.
    Borschel MW; Choe YS; Kajzer JA
    Clin Pediatr (Phila); 2014 Dec; 53(14):1375-82. PubMed ID: 25009115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolyzed Formula With Reduced Protein Content Supports Adequate Growth: A Randomized Controlled Noninferiority Trial.
    Ahrens B; Hellmuth C; Haiden N; Olbertz D; Hamelmann E; Vusurovic M; Fleddermann M; Roehle R; Knoll A; Koletzko B; Wahn U; Beyer K
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):822-830. PubMed ID: 29216020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants.
    Rigo J; Schoen S; Verghote M; van Overmeire B; Marion W; Abrahamse-Berkeveld M; Alliet P
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31331065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < or = 6 y of age: results from the German Infant Nutritional Intervention Study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2009 Jun; 89(6):1846-56. PubMed ID: 19369380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life.
    Turck D; Grillon C; Lachambre E; Robiliard P; Beck L; Maurin JL; Kempf C; Bernet JP; Marx J; Lebrun F; Van Egroo LD
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):364-71. PubMed ID: 16954961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of hydrolyzed protein infant formulas on growth--extended follow-up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1803S-1807S. PubMed ID: 21849601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new partially hydrolyzed whey-based follow-on formula with age-adapted protein content supports healthy growth during the first year of life.
    Billeaud C; Adamon L; Piloquet H; Hays NP; Dupuis L; Metreau I; Léké A
    Front Pediatr; 2022; 10():937882. PubMed ID: 36245743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
    Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
    BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolonged exposure to partially hydrolyzed milk protein.
    Moran JR
    J Pediatr; 1992 Nov; 121(5 Pt 2):S90-4. PubMed ID: 1447640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential growth patterns among healthy infants fed protein hydrolysate or cow-milk formulas.
    Mennella JA; Ventura AK; Beauchamp GK
    Pediatrics; 2011 Jan; 127(1):110-8. PubMed ID: 21187303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and tolerance of healthy, term infants fed lower protein extensively hydrolyzed or amino acid-based formula: double-blind, randomized, controlled trial.
    Adams CB; Johnston WH; Deulofeut H; Leader J; Rhodes R; Yeiser M; Harris CL; Wampler JL; Hill RJ; Cooper T
    BMC Pediatr; 2021 Jul; 21(1):323. PubMed ID: 34289820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved general health status in an unselected infant population following an allergen-reduced dietary intervention programme: the ZUFF-STUDY-PROGRAMME. Part II: infant growth and health status to age 6 months. ZUg-FrauenFeld.
    Exl BM; Deland U; Secretin MC; Preysch U; Wall M; Shmerling DH
    Eur J Nutr; 2000 Aug; 39(4):145-56. PubMed ID: 11079734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial.
    Gibson RA; Barclay D; Marshall H; Moulin J; Maire JC; Makrides M
    Br J Nutr; 2009 Jun; 101(11):1706-13. PubMed ID: 19134240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth, Gastrointestinal Tolerance and Stool Characteristics of Healthy Term Infants Fed an Infant Formula Containing Hydrolyzed Whey Protein (63%) and Intact Casein (37%): A Randomized Clinical Trial.
    Wu SL; Ding D; Fang AP; Chen PY; Chen S; Jing LP; Chen YM; Zhu HL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29144393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pooled Analysis of Growth and Tolerance of Infants Exclusively Fed Partially Hydrolyzed Whey or Intact Protein-Based Infant Formulas.
    Czerkies LA; Kineman BD; Cohen SS; Reichert H; Carvalho RS
    Int J Pediatr; 2018; 2018():4969576. PubMed ID: 30515226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth in preterm infants fed either a partially hydrolyzed whey or an intact casein/whey preterm infant formula.
    Florendo KN; Bellflower B; van Zwol A; Cooke RJ
    J Perinatol; 2009 Feb; 29(2):106-11. PubMed ID: 18716627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A partially hydrolyzed formula with synbiotics supports adequate growth and is well tolerated in healthy, Chinese term infants: A double-blind, randomized controlled trial.
    Wang Y; Li Z; Wu JL; Zhang L; Liu M; Tan M; Botma A; Liu M; Mulder KA; Abrahamse-Berkeveld M; Cai W
    Nutrition; 2021; 91-92():111472. PubMed ID: 34626956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and Tolerance of Term Infants Fed Formula With Probiotic Lactobacillus reuteri.
    Cekola PL; Czerkies LA; Storm HM; Wang MH; Roberts J; Saavedra JM
    Clin Pediatr (Phila); 2015 Oct; 54(12):1175-84. PubMed ID: 25758426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.